For: | Kurniawan DW, Storm G, Prakash J, Bansal R. Role of spleen tyrosine kinase in liver diseases. World J Gastroenterol 2020; 26(10): 1005-1019 [PMID: 32205992 DOI: 10.3748/wjg.v26.i10.1005] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i10/1005.htm |
Number | Citing Articles |
1 |
Rudradip Das, Gayatri Tambe, Amit Shard. Sulfonamides as tyrosine kinase modulators – A promising class of anticancer agents. Results in Chemistry 2023; 5: 100950 doi: 10.1016/j.rechem.2023.100950
|
2 |
Tobias Puengel, Frank Tacke. Sinusoidal Cells in Liver Diseases. 2024; : 483 doi: 10.1016/B978-0-323-95262-0.00024-3
|
3 |
Diego E. Andrade-Brito, Diana L. Núñez-Ríos, José Jaime Martínez-Magaña, Sheila T. Nagamatsu, Gregory Rompala, Lea Zillich, Stephanie H. Witt, Shaunna L. Clark, Maria C. Lattig, Janitza L. Montalvo-Ortiz. Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1345410
|
4 |
Young-Su Yi, Han Gyung Kim, Ji Hye Kim, Woo Seok Yang, Eunji Kim, Jae Gwang Park, Nur Aziz, Narayanan Parameswaran, Jae Youl Cho. Syk promotes phagocytosis by inducing reactive oxygen species generation and suppressing SOCS1 in macrophage-mediated inflammatory responses. International Journal of Immunopathology and Pharmacology 2022; 36 doi: 10.1177/03946320221133018
|
5 |
Emmanuel Oshiogwe Okwuofu, Audrey Chee Hui Yong, Jonathan Chee Woei Lim, Johnson Stanslas. Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma. Pharmacological Research 2022; 181: 106280 doi: 10.1016/j.phrs.2022.106280
|
6 |
Lei Liu, Jia Guo, Xin-lu Pang, Wen-jun Shang, Zhi-gang Wang, Jun-xiang Wang, Xian-lei Yang, Gui-wen Feng. Exploration of the mechanism of NORAD activation of TGF-β1/Smad3 through miR-136-5p and promotion of tacrolimus-induced renal fibrosis. Renal Failure 2023; 45(1) doi: 10.1080/0886022X.2022.2147083
|
7 |
Yuxin Shao, Su Zhang, Yanfen Zhang, Zhongcheng Liu. Recent advance of spleen tyrosine kinase in diseases and drugs. International Immunopharmacology 2021; 90: 107168 doi: 10.1016/j.intimp.2020.107168
|
8 |
Xuejiao Chen, Ziyi Wang, Sheng Han, Zeng Wang, Yu Zhang, Xiangdong Li, Nan Xia, Wenjie Yu, Chenyang Jia, Yong Ni, Liyong Pu. Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment. Cell Death & Disease 2021; 12(12) doi: 10.1038/s41419-021-04403-2
|
9 |
Manish Paul, Amrita Banerjee, Smarajit Maiti, Debanjan Mitra, Pradeep K. DasMohapatra, Hrudayanath Thatoi.
Evaluation of substrate specificity and catalytic promiscuity of
Bacillus albus
cellulase: an insight into
in silico
proteomic study aiming at enhanced production of renewable energy
. Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2295971
|
10 |
Yaping Zhao, Rongrong Liu, Miaomiao Li, Pengfei Liu. The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases. Heliyon 2022; 8(12): e12130 doi: 10.1016/j.heliyon.2022.e12130
|
11 |
Yao Zhang, Wu‐Hao Xiao, Yi‐Xiong Huang, Yi‐Ya Yang, Sha‐Xi Ouyang, Yu‐Mei Liang, Kang‐Han Liu. miR‐128‐3p inhibits high‐glucose‐induced peritoneal mesothelial cells fibrosis via PAK2/SyK/TGF‐β1 axis. Therapeutic Apheresis and Dialysis 2023; 27(2): 343 doi: 10.1111/1744-9987.13912
|
12 |
Bingting Yu, Ruslan Mamedov, Gwenny M. Fuhler, Maikel P. Peppelenbosch. Drug Discovery in Liver Disease Using Kinome Profiling. International Journal of Molecular Sciences 2021; 22(5): 2623 doi: 10.3390/ijms22052623
|
13 |
Wenchun Zeng, Xiangwei Xu, Fang Xu, Fang Zhu, Yuecui Li, Ji Ma. Exploring Key Genes with Diagnostic Value for Nonalcoholic Steatohepatitis Based on Bioinformatics Analysis. ACS Omega 2023; 8(23): 20959 doi: 10.1021/acsomega.3c01709
|
14 |
Vanktesh Kumar, Navjot Kaur, Sanjeev Sahu, Vikas Sharma, Deepak Kumar, Ajit Sharma, Pankaj Wadhwa. Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A
Comprehensive Review. Current Medicinal Chemistry 2023; 30(13): 1464 doi: 10.2174/0929867329666220727122952
|
15 |
Chan Mo, Shuwen Xie, Bin Liu, Weichao Zhong, Ting Zeng, Sha Huang, Yuqi Lai, Guanghui Deng, Chuying Zhou, Weixin Yan, Yuyao Chen, Shaohui Huang, Lei Gao, Zhiping Lv. Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death & Disease 2021; 12(1) doi: 10.1038/s41419-020-03277-0
|
16 |
Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors. SAR and QSAR in Environmental Research 2024; 35(4): 325 doi: 10.1080/1062936X.2024.2345618
|
17 |
Lei Wang, Xiwen Xu, Ziwei Zhang, Kaimin Li, Yingming Yang, Weiwei Zheng, Hejun Sun, Songlin Chen. Transcriptome analysis and protein-protein interaction in resistant and susceptible families of Japanese flounder (Paralichthys olivaceus) to understand the mechanism against Edwardsiella tarda. Fish & Shellfish Immunology 2022; 123: 265 doi: 10.1016/j.fsi.2022.02.055
|
18 |
Liwei Wang, Xuecong Zhang, Yinqiao Huang, Zihan Xu, Dongxuan Ni, Xiaoli Li, Yafang Ke, Weilie Xiao, Ruihan Zhang. Design and synthesis of novel pyrrolo[2,3-d]pyrimidine derivatives as potent JAK3 and SYK dual inhibitors. Journal of Molecular Structure 2024; 1318: 139213 doi: 10.1016/j.molstruc.2024.139213
|
19 |
Wenbin Gong, Peizhao Liu, Tao Zheng, Xiuwen Wu, Yun Zhao, Jianan Ren. The ubiquitous role of spleen tyrosine kinase (Syk) in gut diseases: From mucosal immunity to targeted therapy. International Reviews of Immunology 2022; 41(5): 552 doi: 10.1080/08830185.2021.1962860
|